No connection

Search Results

ALKS vs OPCH

ALKS
Alkermes plc
BEARISH
Price
$27.76
Market Cap
$4.63B
Sector
Healthcare
AI Confidence
85%
OPCH
Option Care Health, Inc.
NEUTRAL
Price
$28.34
Market Cap
$4.45B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
ALKS
19.41
OPCH
22.32
Forward P/E
ALKS
13.4
OPCH
13.33
P/B Ratio
ALKS
2.53
OPCH
3.35
P/S Ratio
ALKS
3.13
OPCH
0.79
EV/EBITDA
ALKS
14.61
OPCH
13.38

Profitability

Gross Margin
ALKS
86.69%
OPCH
19.26%
Operating Margin
ALKS
15.11%
OPCH
6.24%
Profit Margin
ALKS
16.37%
OPCH
3.67%
ROE
ALKS
14.72%
OPCH
15.2%
ROA
ALKS
6.99%
OPCH
6.14%

Growth

Revenue Growth
ALKS
-10.6%
OPCH
8.8%
Earnings Growth
ALKS
-67.0%
OPCH
1.3%

Financial Health

Debt/Equity
ALKS
0.04
OPCH
0.96
Current Ratio
ALKS
3.55
OPCH
1.52
Quick Ratio
ALKS
1.7
OPCH
0.9

Dividends

Dividend Yield
ALKS
--
OPCH
--
Payout Ratio
ALKS
0.0%
OPCH
0.0%

AI Verdict

ALKS BEARISH

ALKS exhibits a weak Piotroski F-Score of 4/9, indicating marginal financial health, and lacks an Altman Z-Score, raising concerns about default risk. Despite a strong Graham Number of $18.80 and intrinsic value estimate of $10.01, the current price of $27.76 trades at a significant premium, especially given deteriorating growth and profitability metrics. The company shows a sharp decline in revenue and earnings (YoY: -10.6% and -67.0%), with recent quarterly earnings missing expectations and negative Q/Q trends. Insider selling activity over the past six months further undermines confidence, despite strong historical earnings surprises. The market appears to be pricing in future recovery, but current fundamentals suggest caution.

Strengths
Strong gross margin of 86.69% indicates high product pricing power and cost control
Exceptionally low debt/equity ratio of 0.04 reflects conservative capital structure and strong financial stability
High current ratio (3.55) and quick ratio (1.70) signal robust short-term liquidity
Risks
Piotroski F-Score of 4/9 indicates weak financial health, with only marginal stability
Significant year-over-year earnings and revenue decline (-67.0% and -10.6%) suggest deteriorating business momentum
Recent insider selling activity (4 transactions, $0.77M value) signals potential internal skepticism
OPCH NEUTRAL

OPCH exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency. However, the stock is trading at a significant premium to its Graham Number ($15.54) and Intrinsic Value ($11.37), suggesting a valuation disconnect based on defensive metrics. While analysts maintain a 'strong_buy' rating with a target of $40.09, this optimism is countered by bearish insider selling and a completely bearish technical trend. The outlook is balanced between strong balance sheet health and an overextended valuation relative to current earnings growth.

Strengths
Strong Piotroski F-Score (7/9) indicating high financial health
Healthy ROE of 15.20% and ROA of 6.14%
Attractive Price/Sales ratio of 0.79
Risks
Significant overvaluation relative to Graham and Intrinsic value models
Bearish insider sentiment with recent selling activity
Negative technical trend (0/100)

Compare Another Pair

ALKS vs OPCH: Head-to-Head Comparison

This page compares Alkermes plc (ALKS) and Option Care Health, Inc. (OPCH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile